DPI and CDC to provide up to $200m funding to KELIX bio

This product is currently unavailable.

Description

628 Development Partners International (DPI) and CDC Group (CDC, to be renamed British International Investment), the UK’s development finance institution that will shortly be renamed British International Investment (BII), today announced that have signed an agreement for KELIX bio to acquire Pharmaceutical Institute (PHI), a Moroccan-headquartered producer and distributor of generic and therapeutic pharmaceuticals.

Recognized by industry leaders for extensive coverage on African Asset Management

DPI and CDC to provide up to $200m funding to KELIX bio

Description

Stock Exchange of Mauritius: Expanding Horizons with SEMX, New Initiatives, and Global Growth Strategy

Meeting Wth Verod

Gender-Inclusive Capital to Build Africa's Investment Future

Mauritius International Financial Centre: Strategic Innovations for a Future-Proof and Sustainable Competitive Edge

Meeting Change Head-On: Post-Election Operational Strategies for South African Investment Managers

Africa’s Energy Sector to Litigate Banks and Financiers for Financial Apartheid in Oil and Gas Sector

AIIF4 Closes at Hard Cap, Exceeding Fundraising Target by 50%

RMB's Report Highlights Africa’s Top Investment Economies

CLEAR Fund Achieves $200m First Close